SEC Form 3 · accession 0001144204-17-051026
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dorman Followwill
Director
Period of report
Sep 26, 2017
Accepted (ET)
Oct 2, 2017 · 8:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,130 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney